These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6335900)

  • 41. Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.
    Zerwekh JE; Sakhaee K; Pak CY
    J Clin Endocrinol Metab; 1985 Mar; 60(3):615-7. PubMed ID: 3871787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcergy and calciphylaxis: timed appearance of gamma-carboxyglutamic acid and osteocalcin in mineral deposits.
    Lian JB; Boivin G; Patterson-Allen P; Grynpas M; Walzer C
    Calcif Tissue Int; 1983 Jul; 35(4-5):555-61. PubMed ID: 6311379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone.
    Price PA; Urist MR; Otawara Y
    Biochem Biophys Res Commun; 1983 Dec; 117(3):765-71. PubMed ID: 6607731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Osteocalcin (BGP) values in postmenopausal osteoporosis before and after treatment with calcitonin].
    Rico H; Cabranes JA; Núñez-Torrón M; Higueras JC; Hernández ER
    Med Clin (Barc); 1986 May; 86(19):791-3. PubMed ID: 3488474
    [No Abstract]   [Full Text] [Related]  

  • 45. Measurement of osteocalcin.
    Lee AJ; Hodges S; Eastell R
    Ann Clin Biochem; 2000 Jul; 37 ( Pt 4)():432-46. PubMed ID: 10902858
    [No Abstract]   [Full Text] [Related]  

  • 46. Differences in serum bone GLA protein with age and sex.
    Epstein S; Poser J; McClintock R; Johnston CC; Bryce G; Hui S
    Lancet; 1984 Feb; 1(8372):307-10. PubMed ID: 6141381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkaline phosphatase isoenzymes and osteocalcin in serum of normal subjects.
    Steinberg KK; Rogers TN
    Ann Clin Lab Sci; 1987; 17(4):241-50. PubMed ID: 3497607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.
    Caniggia A; Nuti R; Galli M; Loré F; Turchetti V; Righi GA
    Calcif Tissue Int; 1986 Jun; 38(6):328-32. PubMed ID: 3089554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?
    Als OS; Gotfredsen A; Riis BJ; Christiansen C
    Ann Rheum Dis; 1985 Jun; 44(6):406-11. PubMed ID: 3874608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteocalcin. Biochemical considerations and clinical applications.
    Lian JB; Gundberg CM
    Clin Orthop Relat Res; 1988 Jan; (226):267-91. PubMed ID: 3275514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.
    Delmas PD; Stenner D; Wahner HW; Mann KG; Riggs BL
    J Clin Invest; 1983 May; 71(5):1316-21. PubMed ID: 6304145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carboxylated calcium-binding proteins and vitamin K.
    Gallop PM; Lian JB; Hauschka PV
    N Engl J Med; 1980 Jun; 302(26):1460-6. PubMed ID: 6990261
    [No Abstract]   [Full Text] [Related]  

  • 54. Measures of bone loss in rheumatoid arthritis.
    Weisman MH; Orth RW; Catherwood BD; Manolagas SC; Deftos LJ
    Arch Intern Med; 1986 Apr; 146(4):701-4. PubMed ID: 3963951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology].
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Presse Med; 1986 Apr; 15(14):643-6. PubMed ID: 2939433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The changes of bone gamma-carboxyglutamic acid-containing protein in bone and serum of developing chick.
    Tsutsumi C; Hosoya N; Moriuchi S
    J Nutr Sci Vitaminol (Tokyo); 1983 Dec; 29(6):643-54. PubMed ID: 6676447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LVAD mineralization and gamma-carboxyglutamic acid containing proteins in normal and pathologically mineralized tissues.
    Lian JB; Levy RJ; Bernhard W; Szycher M
    Trans Am Soc Artif Intern Organs; 1981; 27():683-9. PubMed ID: 6977229
    [No Abstract]   [Full Text] [Related]  

  • 58. Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease.
    Hyldstrup L; Clemmensen I; Jensen BA; Transbøl I
    Scand J Clin Lab Invest; 1988 Nov; 48(7):611-9. PubMed ID: 3264412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism.
    Ljunghall S; Hällgren R; Rastad J
    Exp Clin Endocrinol; 1985 Dec; 86(2):218-22. PubMed ID: 3879222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S; Traberg H; Raja R; Poser J
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.